Psychemedics Corp
PMDDelisted Dec 13, 2024- Industry
- Services-Medical Laboratories
- SEC CIK
- 0000806517
Psychemedics Corp was delisted on Dec 13, 2024; its insiders filed their last Form 4 on Dec 17, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $2.85M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Psychemedics Corp as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −2 vs. Q3 2023
- Shares held
- 1.29M
- −141.5K (−9.9%) vs. Q3 2023
- Total value
- $3.82M
- −$1.86M (−32.8%) vs. Q3 2023
- New holders
- 1
- 6 more added
- Sold out
- 3
- 10 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $441.7K |
| Q3 2025 | 1 | $582.4K |
| Q2 2025 | 1 | $618.3K |
| Q1 2025 | 1 | $643.2K |
| Q4 2024 | 3 | $708.7K |
| Q3 2024 | 21 | $2.85M |
| Q2 2024 | 26 | $2.87M |
| Q1 2024 | 22 | $3.54M |
| Q4 2023 | 23 | $3.82M |
| Q3 2023 | 25 | $5.68M |
| Q2 2023 | 21 | $6.32M |
| Q1 2023 | 20 | $7.34M |
| Q4 2022 | 22 | $6.93M |
| Q3 2022 | 23 | $9.54M |
| Q2 2022 | 21 | $9.55M |
| Q1 2022 | 25 | $11.0M |
| Q4 2021 | 25 | $11.4M |
| Q3 2021 | 28 | $13.9M |
| Q2 2021 | 28 | $12.4M |
| Q1 2021 | 31 | $11.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Psychemedics Corp; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 28 | $0 | 0.00% | −2,106−98.7% | Reduced |
| Bank of America Corp | 3 | $9 | 0.00% | +3 | New |
| JPMorgan Chase & Co | 8 | $24 | 0.00% | +3+60.0% | Added |
| Caldwell Sutter Capital, Inc. | 30 | $89 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 37 | $110 | 0.00% | +2+5.7% | Added |
| FMR LLC | 625 | $1.85K | 0.00% | +525+525.0% | Added |
| Provenance Wealth Advisors, LLC | 772 | $2.29K | 0.00% | 00.0% | Unchanged |
| Your Advocates Ltd., LLP | 1,400 | $4.14K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,321 | $6.87K | 0.00% | +584+33.6% | Added |
| Morgan Stanley | 3,501 | $10.4K | 0.00% | −999−22.2% | Reduced |
| Northern Trust Corp | 15,310 | $45.3K | 0.00% | −1,554−9.2% | Reduced |
| Citadel Advisors LLC | 16,200 | $48.0K | 0.00% | −4,238−20.7% | Reduced |
| Santa Monica Partners LP | 20,000 | $59.0K | 0.04% | 00.0% | Unchanged |
| Crawford Investment Counsel Inc | 20,098 | $59.5K | 0.00% | −12,000−37.4% | Reduced |
| Dimensional Fund Advisors LP | 36,117 | $106.9K | 0.00% | −2,067−5.4% | Reduced |
| Geode Capital Management, LLC | 36,596 | $108.4K | 0.00% | 00.0% | Unchanged |
| Wedbush Securities Inc | 48,664 | $144.0K | 0.01% | +6,250+14.7% | Added |
| BlackRock Inc. | 77,267 | $228.7K | 0.00% | −114−0.1% | Reduced |
| Ancora Advisors, LLC | 78,173 | $231.4K | 0.01% | −200−0.3% | Reduced |
| RBF Capital, LLC | 142,142 | $420.7K | 0.03% | −2,089−1.4% | Reduced |
| Vanguard Group Inc | 251,283 | $743.8K | 0.00% | +132+0.1% | Added |
| Renaissance Technologies LLC | 265,563 | $786.0K | 0.00% | −8,100−3.0% | Reduced |
| 22NW, LP | 274,418 | $812.3K | 0.53% | 00.0% | Unchanged |
| Cannell Capital LLC | 0 | $0 | 0.00% | −74,794−100.0% | Sold out |
| Wealth Effects LLC | 0 | $0 | 0.00% | −40,701−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |